Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Irvine, Calif., Jan. 8, 2025 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role, he will support a range of strategic and clinical goals for Oncocyte. Dr. Billings is a recognized pioneer in genomics […]

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

Study of Vendaje® versus standard of care aims to show superior wound treatment, supporting market expansion POMPANO BEACH, Fla., January 8, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces the initiation of the BR-AM-DFU […]

UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million

Company Secures $20 Million Funding Commitment to Advance Aerospace & Defense Initiatives WEWAHITCHKA-PORT ST JOE, Fla., January 8, 2025 – PRISM MediaWire – UAV Corp (OTC: UMAV), a leader in innovative manned and unmanned aerial vehicle (UAV) technologies, is pleased to announce an additional reduction in its authorized share count. Building upon the strategic reduction […]

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

Following the Closing of its 2024 Transactions, EzFill is Now Operating in Miami, West Palm Beach, Orlando, Tampa, Jacksonville, Los Angeles, San Francisco, Nashville, Detroit, Dallas, Houston, Austin, San Antonio, and Phoenix MIAMI, January 07, 2025 – EzFill Holdings, Inc. (NASDAQ: EZFL), a leading mobile fueling company, today announced the completion of its purchase of […]

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York, January 07, 2024 –PRISM MediaWire – PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty […]

AmpliTech Group Announces Receipt of Notice of Allowance for Another Patent For Its LNA Technology

Hauppauge, NY, January 6, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today […]

Blaqclouds Provides Update on the Successful Soft Launch of ShopwithCrypto.io

Revolutionizing Crypto Spendability with Real-Time Gift Card Purchases ROBESONIA, Pa., Jan. 06, 2025 – PRISM MediaWire – Blaqclouds, Inc. (OTC: BCDS) is thrilled to announce the impressive results of the soft launch of ShopwithCrypto.io, a groundbreaking platform that brings real-world spendability to cryptocurrency holders. During this limited launch phase, the platform opened to 500 crypto enthusiasts, achieving remarkable […]

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Irvine, Calif., January 6, 2025 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a leader in diagnostic technology, today announced a significant milestone in the advancement of patient care for kidney transplant patients. The Molecular Diagnostics program (MolDX) has confirmed the use of VitaGraft Kidney to monitor patients with newly developed donor-specific antibodies (dnDSA+) for […]